Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sabra Health Care REIT (SBRA)

Sabra Q3 revenue rises to $249.6 million; company says 2026 guidance midpoint increased

Positive Impact 4 of 5 earnings

Sabra Health Care REIT reported third quarter 2026 total revenues of $249.6 million, up from $190.0 million a year earlier, and net income of $0.11 per diluted share, compared with $0.09. Normalized FFO was $0.39 per diluted share, up from $0.36, and the company updated 2026 normalized FFO guidance to $1.540 to $1.550 per share, which its CEO said was increased at the midpoint.

Key points

  • Total revenues were $249.6 million for the quarter, versus $190.0 million in the third quarter of 2025.
  • Normalized FFO was $0.39 per diluted share, versus $0.36; normalized AFFO was $0.41, versus $0.38.
  • Full-year 2026 guidance: net income $0.265 to $0.275 per share and normalized FFO $1.540 to $1.550 per share.
  • Sabra was awarded an additional $425 million of investments and declared a quarterly dividend of $0.30 per share, payable November 30, 2026.

The filing

CompanySabra Health Care REIT (SBRA)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:05 PM ET
Accession number0001492298-26-000032

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.